InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,868.69
(
0.47%
)
US TECH 100
19,799.20
(
0.76%
)
Dow Jones
43,298.25
(
0.14%
)
Brent Oil
72.86
(
-1.75%
)
Bitcoin
68,915.96
(
2.22%
)
Post# of 253398
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120586
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 35743

Tuesday, 10/17/2006 5:29:36 PM

Tuesday, October 17, 2006 5:29:36 PM

Post# of 253398
It’s your baby and after the Q3 CC will be fine. But bear in mind that this board has a large number of lurkers and some of them are probably looking for good info about ITMN right now.

>Its interesting that InterMune mentioned the importance of Pegasys remaining in the body longer [I presume more than PEG-Intron] and that would be favorable to assist in cross-resistance…<

I suspect that this is a non-issue in practice and it was little more than a gratuitous plug for Roche. The peg-interferon battle between Roche and SGP reminds me of the negative ads in some political campaigns.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up